Charles N York II's Net Worth
Charles N York II's net worth is estimated to be at least $2,767,475.64 as of 11/20/2024. CoreStreet's estimation of Charles N York II's net worth is based on their sale of stock and current holding of stock.
Charles N York II is CFO at Day One Biopharmaceuticals Inc. They have executed at least 22 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,633 units of DAWN stock on 08/16/2024. Their biggest sale was on 05/01/2024 when they sold 52,183 units of Day One Biopharmaceuticals Inc stock for $933,553.87. They typically trade 5 times per year.
Total value of insider buys:
- $146,131.32
Total value of insider sells:
- $2,621,344.32
Most recent insider trade:
- Aug. 16, 2024
Charles N York II's Insider Trading History
| Day One Biopharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2024 | CFO | 2,633 | $14.00 | Sell | $36,862.00 |
May 16, 2024 | CFO | 2,675 | $16.08 | Sell | $43,014.00 |
May 3, 2024 | CFO | 8,078 | $17.85 | Sell | $144,192.30 |
May 1, 2024 | CFO | 52,183 | $17.89 | Sell | $933,553.87 |
Feb. 16, 2024 | CFO | 2,666 | $15.25 | Sell | $40,656.50 |
Nov. 16, 2023 | CFO | 956 | $11.69 | Sell | $11,175.64 |
Aug. 17, 2023 | CFO | 922 | $13.86 | Sell | $12,778.92 |
May 16, 2023 | CFO | 955 | $13.12 | Sell | $12,529.60 |
Feb. 16, 2023 | CFO | 930 | $19.57 | Sell | $18,200.10 |
Jan. 20, 2023 | CFO | 10,000 | $22.75 | Sell | $227,500.00 |
Dec. 20, 2022 | CFO | 10,000 | $20.07 | Sell | $200,700.00 |
Nov. 21, 2022 | CFO | 10,000 | $20.76 | Sell | $207,600.00 |
Nov. 16, 2022 | CFO | 430 | $21.46 | Sell | $9,227.80 |
Nov. 1, 2022 | CFO | 10,000 | $20.03 | Sell | $200,300.00 |
Oct. 3, 2022 | CFO | 10,000 | $20.05 | Sell | $200,500.00 |
Aug. 16, 2022 | CFO | 1,089 | $24.31 | Sell | $26,473.59 |
Aug. 4, 2022 | CFO | 10,000 | $20.05 | Sell | $200,500.00 |
July 18, 2022 | CFO | 2,500 | $20.00 | Sell | $50,000.00 |
July 5, 2022 | CFO | 800 | $20.00 | Sell | $16,000.00 |
July 1, 2022 | CFO | 1,479 | $20.00 | Sell | $29,580.00 |
| Aeglea Bio Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 5, 2017 | CFO | 25,959 | $4.48 | Buy | $116,296.32 |
Dec. 1, 2017 | CFO | 6,500 | $4.59 | Buy | $29,835.00 |